Anavex Life Sciences Corp. (AVXL): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-4, first reflected in a filing dated 2015-12-29. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

86.67M
As of 2025-09-30
92.70M
As of 2026-06-30
+3.6%
3-year compound annual growth
+6.9%
5-year compound annual growth
+10.5%
10-year compound annual growth
2010-09-30: 23.52M2011-09-30: 26.57M2012-09-30: 30.24M2013-09-30: 37.24M2014-09-30: 11.80M2015-09-30: 32.04M2016-09-30: 36.17M2017-09-30: 43.33M2018-09-30: 45.93M2019-09-30: 52.65M2020-09-30: 62.05M2021-09-30: 75.92M2022-09-30: 77.94M2023-09-30: 82.07M2024-09-30: 84.80M2025-09-30: 86.67M86.67M
2010-09-30 Shares Outstanding (shares) 2025-09-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-09-3086.67M+2.2%2026-08-28, Balance as of period end
2024-09-3084.80M+3.3%2026-08-28, Balance as of period end
2023-09-3082.07M+5.3%2024-12-23, Balance as of period end
2022-09-3077.94M+2.7%2023-11-27, Balance as of period end
2021-09-3075.92M+22.4%2022-11-28, Balance as of period end
2020-09-3062.05M+17.8%2021-11-24, Balance as of period end
2019-09-3052.65M+14.6%2020-12-28, Balance as of period end
2018-09-3045.93M+6.0%2019-12-16, Balance as of period end
2017-09-3043.33M+19.8%2019-01-25, Balance as of period end
2016-09-3036.17M+12.9%2017-12-11, Balance as of period end
2015-09-3032.04M+171.6%2016-12-14, Balance as of period end
2014-09-3011.80Mn/c2015-12-29, Balance as of period end
2013-09-3037.24M+23.1%2014-12-29, Balance as of period end
2012-09-3030.24M+13.8%2013-12-30, Balance as of period end
2011-09-3026.57M+13.0%2012-12-31, Balance as of period end
2010-09-3023.52Mn/a2011-12-22, Balance as of period end